thiazoles has been researched along with Lymphoma, Large-Cell, Anaplastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Annereau, JP; Bailly, C; Barret, JM; Brel, V; Delsol, G; Fahy, J; Fournier, E; Imbert, T; Kruczynski, A; Marchand, A; Mayer, P; Vispé, S | 1 |
1 other study(ies) available for thiazoles and Lymphoma, Large-Cell, Anaplastic
Article | Year |
---|---|
Antitumor activity of pyridoisoquinoline derivatives F91873 and F91874, novel multikinase inhibitors with activity against the anaplastic lymphoma kinase.
Topics: Anaplastic Lymphoma Kinase; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; G1 Phase; Lung Neoplasms; Lymphoma, Large-Cell, Anaplastic; Mice; Mice, Inbred ICR; Mice, SCID; Ovarian Neoplasms; Protein Kinase Inhibitors; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Quinolizines; Receptor Protein-Tyrosine Kinases; Recombinant Fusion Proteins; Thiazoles; Xenograft Model Antitumor Assays | 2009 |